Vectura Group PLC (VEC.L)
VEC.L on London Stock Exchange
81.00GBp
18 Jun 2013
81.00GBp
18 Jun 2013
Price Change (% chg)
-1.00p (-1.22%)
-1.00p (-1.22%)
Prev Close
82.00p
82.00p
Open
81.00p
81.00p
Day's High
81.25p
81.25p
Day's Low
81.00p
81.00p
Volume
73,941
73,941
Avg. Vol
478,197
478,197
52-wk High
98.50p
98.50p
52-wk Low
64.25p
64.25p
VEC.L
About
Vectura Group plc (Vectura) is a developer of therapies principally for the treatment of respiratory diseases. The Company is engaged in developing treatments for respiratory diseases. Vectura’s products target diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The Company’s pharmaceutical business... (more)
Overall
| Beta: | 0.21 |
| Market Cap (Mil.): | £274.93 |
| Shares Outstanding (Mil.): | 335.29 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| VEC.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 31.05 | 31.28 |
| EPS (TTM): | -0.02 | -- | -- |
| ROI: | -4.25 | 19.56 | 18.90 |
| ROE: | -4.30 | 20.32 | 19.80 |
BRIEF-Vectura says trading in line
LONDON, Feb 13 - Vectura Group PLC : * Financial performance from 1 October 2012 to date has been in line with the
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
